Canada markets close in 5 hours 38 minutes

Khiron Life Sciences Corp. (KHRNF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.0940+0.0031 (+3.41%)
As of 09:58AM EDT. Market open.
Sign in to post a message.
  • M
    MoonShot
    Clinica Zerenia Rio Brazil is up and running :) Expect a NR this week I can only assume

    Goole search the name and it appears as open and with hours posted!

    Long and Strong
  • M
    MoonShot
    Chris Naprawa participated in the financing that closed June 10th and picked up 1M shares at the 0.15 price.

    https://www.canadianinsider.com/company-insider-filings?ticker=KHRN
  • P
    Pric
    Khiron Life Sciences will host a special AMA (Ask me Anything) session with Alvaro Torres, Khiron Chief Executive Officer and Director, Franziska Katterbach, President Khiron Europe and Chris Naprawa, Chairman of Khiron Board of Directors, to discuss the company's most recent operational and financial updates.
    Please submit your questions in advance to investors@khiron.ca

    https://event.on24.com/wcc/r/3835059/9A83BB2332EE94D9CA5E3A95977E3678
  • S
    Slim
    Buying more .. good AMA call today!
  • D
    David
    Bought more today at .098
  • D
    David
    I added more at .11 usd. I think we've finally bottomed out. I was pleasantly surprised that we didn't drop more after the offering, to be honest. Now that we have some breathing room to get us to profitability I think this is a great value at these levels.
  • T
    Tim
    Here are the numbers. That's how much we are going to bleed...

    https://investors.khiron.ca/investor-information/news-events/press-releases/detail/259/khiron-life-sciences-announces-pricing-and-size-of

    "the Company will issue 26,700,000 units of the Company (each, a "Unit") at a price of C$0.15 per Unit (the "Offering Price") for aggregate gross proceeds of C$4,005,000. "
    KHIRON LIFE SCIENCES ANNOUNCES PRICING AND SIZE OF OVERNIGHT BROKERED OFFERING
    investors.khiron.ca
  • J
    Jonn
    TORONTO, Sept. 13, 2021 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America, is pleased to announce that, further to its September 9, 2021 press release, the Company has received final approval from the TSX Venture Exchange (the "TSXV") to renew its normal course issuer bid to repurchase, for cancellation, up to 8,955,853 common shares of the Company ("Shares"), representing approximately 5% of the Company's presently issued and outstanding
  • L
    Lee
    Insiders have been buying at over 20 cents the last 6 months. no insider selling last 6 months that I see filed.
    Maybe the recent insider buying ads perspective, and its not selling like some have wrongly suggested here.

    Filing
    Date Transaction
    Date Insider Name Ownership
    Type Securities Nature of transaction Volume or Value Price
    Jan 4/22 Jan 4/22 Naprawa, Chris Indirect Ownership Common Shares 10 - Acquisition in the public market 50,000 $0.241
    Dec 23/21 Dec 23/21 Naprawa, Chris Indirect Ownership Common Shares 10 - Acquisition in the public market 150,000 $0.215
    Dec 22/21 Dec 22/21 Torres, Alvaro Francisco Direct Ownership Common Shares 10 - Acquisition in the public market 240,000 $0.205
    Dec 3/21 Dec 3/21 Echeverry, Juan Carlos Direct Ownership Common Shares 10 - Acquisition in the public market 120,000 $0.200
  • M
    Mark
    Was not able to listen to the call. Can anyone summarize what was said regarding the direction
    the company plans to take to improve their cash position?
  • T
    Thomi
    Filing is on sedar:

    Cash 5.1 Mio (I was a bit overoptimistic)

    Receivables 4.3 Mio (showing strong sales trend)

    Cannabis sales 2.65 Mio, already approaching the 1 Mio/month target, keeps increasing nicely
  • J
    Jei Jei
    I see a big gap between stock performance and business fundamentals. While is really disappointing to see, there is light at the end of the tunnel
  • k
    kalle
    In the conference call few days ago did they mention this funding plan at all, anyone know?
  • T
    Thomi
    Cash is king: there are many discussions and concerns re cash. Without having a crystal ball, I see it as follows:

    End of Dec 2021 KHRN had cash of CAD 8.92 Mio + 2.88 Mio receivables - I assume they have collected the receivables in Q1 (basically additional cash most people forget to consider). With an estimated cash burn of CAD 4.5, they are probably down to CAD 7.3 end of Q1.

    With increased sales in Q1 and as a result collecting more in Q2 we are end of Q2 probably at CAD 3.8 Mio and 1 Mio end of Q4 (considering growth quarter over quarter). In Q4 cash flow neutrality is on the horizon as Alvaro announced. From that point on, we start to generate positive FCF in Q1 2023... so we are OK.

    However, additional Cash to further invest in new satellite clinics, Mexico etc. to accelerate growth would still be great so that FCF/profits in 2023 and beyond get even better.
  • M
    Martin
    Lol these reactions. Companies halt trading pending news all the time. Dilutions happened before so they wouldn’t just halt because of that. Shares from .21 to .08 cents in a matter of days but it didn’t halt either. Relaaaax
  • m
    marc
    If they continue to increase medical cannabis sales at 33% month over month, the company might be just under 1mil cash flow negative in two quarters. 33% is conservative considering they have a short history of selling in Europe. It takes a while to ramp up sales.
    Somethings not right in the world if you can't get less than $1mil in financing from multiple sources. They might not even need it if sales increase at a higher percentage.
    We are not going out of business guys/gals. Don't over think this. This is not a clinical stage biotech that has zero sales and needs a huge dilution.
    We will definitely be cash flow positive by q4 and then it's up up from there.
    Hopefully we have a positive conference call.
    GLTA!!
  • D
    David
    Trading halt....wonder if it's just to announce terms of dilution or if there is some other news?
  • M
    Martin
    We saw this coming so it’s good and smart timing on their part. might as well do it after the er pump since we know prices would drop shortly after anyway. I already sold all mine for profit yesterday but should’ve held til today since it went up another two cents plus but didn’t want to risk it. Will be buying more after the sell off bottoms out. Long term is still great but need to take advantage of short term and make moves based on how the stock performed in the past 3 4 years after good news. Good luck to all !